A novel engineered interchain disulfide bond in the constant region enhances the thermostability of adalimumab Fab
We constructed a system for expressing the Fab of the therapeutic human monoclonal antibody adalimumab at a yield of 20 mg/L in the methylotrophic yeast Pichia pastoris. To examine the contribution of interchain disulfide bonds to conformational stability, we prepared adalimumab Fab from which the interchain disulfide bond at the C-terminal region at both the CH{sub 1} and CL domains was deleted by substitution of Cys with Ala (Fab{sub ΔSS}). DSC measurements showed that the Tm values of Fab{sub ΔSS} were approximately 5 °C lower than those of wild-type Fab, suggesting that the interchain disulfide bond contributes to conformational thermostability. Using computer simulations, we designed a novel interchain disulfide bond outside the C-terminal region to increase the stability of Fab{sub ΔSS}. The resulting Fab (mutSS Fab{sub ΔSS}) had the mutations H:V177C and L:Q160C in Fab{sub ΔSS}, confirming the formation of the disulfide bond between CH{sub 1} and CL. The thermostability of mutSS Fab{sub ΔSS} was approximately 5 °C higher than that of Fab{sub ΔSS}. Therefore, the introduction of the designed interchain disulfide bond enhanced the thermostability of Fab{sub ΔSS} and mitigated the destabilization caused by partial reduction of the interchain disulfide bond at the C-terminal region, which occurs in site-specific modification such as PEGylation.